메뉴 건너뛰기
Journal of the American College of Cardiology
Volumn 46, Issue 9, 2005, Pages 1710-1711
On defining aspirin resistance
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; CITRATE SODIUM; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;
EID: 27444444113     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.08.014     Document Type: Editorial
Times cited : (14)
References (10)
  • 1
    • 27444434164 scopus 로고    scopus 로고
    • Overestimation of platelet aspirin resistance detection by thromboelastography platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation
    • U.S. Tantry, K.P. Bliden, P.A. Gurbel Overestimation of platelet aspirin resistance detection by thromboelastography platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1705-1709
    • Tantry, U.S.1    Bliden, K.P.2    Gurbel, P.A.3
  • 2
    • 0016805004 scopus 로고
    • The mechanism of the effect of aspirin on human platelets: I: acetylation of a particulate fraction protein
    • G.J. Roth, P.W. Majerus The mechanism of the effect of aspirin on human platelets: I: acetylation of a particulate fraction protein J Clin Invest 56 1975 624 629
    • (1975) J Clin Invest , vol.56 , pp. 624-629
    • Roth, G.J.1    Majerus, P.W.2
  • 3
    • 0034973565 scopus 로고    scopus 로고
    • Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system
    • S. He, M. Blomback, G. Yoo, R. Sinha, A.H. Henschen-Edman Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system Ann N Y Acad Sci 936 2001 531 535
    • (2001) Ann N Y Acad Sci , vol.936 , pp. 531-535
    • He, S.1    Blomback, M.2    Yoo, G.3    Sinha, R.4    Henschen-Edman, A.H.5
  • 4
    • 0037422559 scopus 로고    scopus 로고
    • Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism
    • A. Undas, W.J. Sydor, K. Brummel, J. Musial, K.G. Mann, A. Szczeklik Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism Circulation 107 2003 17 20
    • (2003) Circulation , vol.107 , pp. 17-20
    • Undas, A.1    Sydor, W.J.2    Brummel, K.3    Musial, J.4    Mann, K.G.5    Szczeklik, A.6
  • 5
    • 0036061713 scopus 로고    scopus 로고
    • Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells
    • A. Tiran, H.J. Gruber, W.F. Graier, A.H. Wagner, E.B. Van Leeuwen, B. Tiran Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells Arterioscler Thromb Vasc Biol 22 2002 1075 1080
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 1075-1080
    • Tiran, A.1    Gruber, H.J.2    Graier, W.F.3    Wagner, A.H.4    Van Leeuwen, E.B.5    Tiran, B.6
  • 6
    • 0025280866 scopus 로고
    • Platelet hyperreactivity and prognosis in survival of myocardial infarction
    • M.D. Trip, V.M. Cats, F.J. van Capelle, J. Vreeken Platelet hyperreactivity and prognosis in survival of myocardial infarction N Engl J Med 322 1990 1549 1554
    • (1990) N Engl J Med , vol.322 , pp. 1549-1554
    • Trip, M.D.1    Cats, V.M.2    Van Capelle, F.J.3    Vreeken, J.4
  • 7
    • 0035838355 scopus 로고    scopus 로고
    • Platelet reactivity characterized prospectively: A determinant of outcome 90 days after percutaneous coronary intervention
    • S.S. Kabbani, M.W. Watkins, T. Ashikaga Platelet reactivity characterized prospectively a determinant of outcome 90 days after percutaneous coronary intervention Circulation 104 2001 181 186
    • (2001) Circulation , vol.104 , pp. 181-186
    • Kabbani, S.S.1    Watkins, M.W.2    Ashikaga, T.3
  • 8
    • 0030664732 scopus 로고    scopus 로고
    • Differential effects of anticoagulants on the activation of platelets ex vivo
    • D.J. Schneider, P.B. Tracy, K.G. Mann, B.E. Sobel Differential effects of anticoagulants on the activation of platelets ex vivo Circulation 96 1997 2877 2883
    • (1997) Circulation , vol.96 , pp. 2877-2883
    • Schneider, D.J.1    Tracy, P.B.2    Mann, K.G.3    Sobel, B.E.4
  • 9
    • 0030610564 scopus 로고    scopus 로고
    • 2+ on GP IIb/IIIa interactions with integrelin: Enhanced GP IIb/IIIa binding and inhibition of platelet aggregation by reductions in concentration of ionized calcium in plasma anticoagulated with citrate
    • 2+ on GP IIb/IIIa interactions with integrelin enhanced GP IIb/IIIa binding and inhibition of platelet aggregation by reductions in concentration of ionized calcium in plasma anticoagulated with citrate Circulation 96 1997 1488 1494
    • (1997) Circulation , vol.96 , pp. 1488-1494
    • Phillips, D.R.1    Teng, W.2    Arfsten, A.3
  • 10
    • 8644286672 scopus 로고    scopus 로고
    • Development of glycoprotein IIb/IIIa antagonists, translation of pharmacodynamic effects into clinical benefit
    • D.J. Schneider, A. Aggarwal Development of glycoprotein IIb/IIIa antagonists, translation of pharmacodynamic effects into clinical benefit Expert Rev Cardiovasc Ther 2 2004 903 913
    • (2004) Expert Rev Cardiovasc Ther , vol.2 , pp. 903-913
    • Schneider, D.J.1    Aggarwal, A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.